BridgeBio Pharma, Inc. (BBIO) Insider Trading

Name: BridgeBio Pharma, Inc. (BBIO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 21, 2026): Neil Kumar (Chief Executive Officer): Sale of 8,721 shares, $601.9K.

Get alerted when insiders trade BBIO

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta